首页> 外文期刊>Journal of Drug Delivery and Therapeutics >FORMULATION & CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIER (NLC) BASED GEL FOR TOPICAL DELIVERY OF ETORICOXIB
【24h】

FORMULATION & CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIER (NLC) BASED GEL FOR TOPICAL DELIVERY OF ETORICOXIB

机译:纳米结构脂质载体(NLC)的凝胶的制备与表征

获取原文
           

摘要

Nanostructured lipid carriers (NLC)-based topical gel of Etoricoxib was prepared with the aim for the treatment of inflammation and allied conditions. The composition of NLC consisted of Stearic acid as solid lipid, oleic acid as liquid lipid and tween 80 as a surfactant. NLCs prepared by melt-emulsification and low temperature solidification techniques were characterized by particle sizing technology, scanning electron microscopy (SEM), and differential scanning calorimetry (DSC). All of the NLC showed high entrapment efficiency ranging from 69% to 76%. Both the entrapment and release rate were affected by the percentage of oleic acid. NLC-F3G-C was selected as best formulation with average particle size of 244 nm and polydispersity index of 0.690 indicating homogeneity in particle size distribution. The higher magnitude of zeta potential of NLC-F3G-C indicates the stability of formulation. The nanoparticulate dispersion was suitably gelled and assessed for Physical appearance, Homogeneity, Spreadability and in-vitro permeation study. In-vitro drug release pattern of developed NLC dispersion gel showed burst and prolong release. It was concluded that developed NLC gel of Etoricoxib holds promise for prolonged availability of drug in the skin tissues and can be used for better management of inflammatory conditions.
机译:制备了基于纳米结构脂质载体(NLC)的Etoricoxib局部用凝胶,旨在治疗炎症和相关疾病。 NLC的组成由作为固体脂质的硬脂酸,作为液体脂质的油酸和作为表面活性剂的吐温80组成。通过熔体乳化和低温固化技术制备的NLCs通过粒度分析技术,扫描电子显微镜(SEM)和差示扫描量热法(DSC)进行了表征。所有的NLC均显示出69%至76%的高包封率。包封率和释放率均受油酸百分比的影响。选择NLC-F3G-C作为最佳配方,平均粒径为244 nm,多分散指数为0.690,表明粒径分布均匀。 NLC-F3G-C的Zeta电位值越高,表明制剂的稳定性越好。将纳米颗粒分散体适当地凝胶化,并评估其物理外观,均质性,可扩展性和体外渗透研究。已开发的NLC分散凝胶的体外药物释放模式显示爆发和延长释放。得出的结论是,已开发的Etoricoxib NLC凝胶有望在皮肤组织中延长药物的可用性,并可用于更好地控制炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号